Peptide antagonists at glutamate and NMDA receptors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 8, 1998
Grant Date -
N/A
app pub date -
Nov 9, 1995
filing date -
May 14, 1993
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention relates to the use of a new type of peptide antagonists at glutamate receptors and a subtype of glutamate receptors (NMDA (N-methyl-D-aspartate)) for the manufacture of a medicament to influence the glutamate receptor and the NMDA-receptor controlled cells such as neurons or glial cells in the central nervous system.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully